Pfizer, Inc. News

Do you have an interest in the products developed by Pfizer, Inc., or are you interested in the performance of the company? If you are you should register for the free Pfizer, Inc. news email from Wiser. Pfizer, Inc. is an American-based pharmaceutical company that researches, develops and manufactures medicines and vaccines. The products developed by the company are used all over the world. They include leading brands like Lipitor, Zithromax and Viagra. The company was founded in 1849 and today is one of the largest pharmaceutical companies in the world. Its current chairman and CEO is Ian Reed. Most analysts expect Pfizer, Inc. to expand through acquisitions over the coming years. The Wiser daily Pfizer, Inc. news email covers this news as well as analysis on the performance of the company, and details about its products. These articles come from the best sources around the web and are delivered in a comprehensive but simple to use format. Sign up today.

Recent Pfizer, Inc. News Coverage
 
Your Weekly Recommendations Monday, July 24, 2017
 
Recommended for you
What America's Corporations Can Do To Tackle Alzheimer's
Forbes • Contributor, Jason Karlawish
Trump meets with Pearl Harbor survivors
Los Angeles Times • Associated Press
DivGro Pulse: July 2017
Seeking Alpha • Ferdis
Ignyta Lights The Fire
Seeking Alpha • Strong Bio
Bad Medicine! Pfizer, Cipla, DRL, other 63 drug firms fail quality test
The Economic Times of India • Prabha Raghavan
Sirukumab's Panel And U.S. Decision For Medicines Company
Seeking Alpha • E.P. Vantage
Europe backs nuclear medicine for cancer that killed Steve Jobs
Reuters
Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval
Reuters
A Drug Maker Spends Big in Washington to Make Itself Heard
The New York Times • Elizabeth Lucas, Jay Hancock, Sydney Lupkin
Trump tweets promotion of pharmaceutical packaging initiative
Los Angeles Times • Associated Press
 
Recommended for You
AARP, Bank of America
What America's Corporations Can Do To Tackle Alzheimer's
ForbesContributor, Jason Karlawish
Alzheimer's is common, costly and harms patients and their caregivers, but there are no effective treatments to slow the disease. This is bad news for companies. Caregivers are absent and distracted employees. Fortunately, companies can accelerate the pace of studies to discover...
Share
Barack Obama, Merck & Co., Inc.
Trump meets with Pearl Harbor survivors
Los Angeles TimesAssociated Press
As part of a weeklong focus on American-made goods, President Trump has posed in a firetruck, donned a white Stetson and chatted about domestically-produced pillows. But the painstakingly arranged "Made in America" events were largely drowned out by the tumult surrounding healthcare...
Share
Pfizer, Inc.
DivGro Pulse: July 2017
Seeking AlphaFerdis
Summary The goal of my monthly pulse articles is to monitor the health of DivGro, my portfolio of dividend growth stocks. These pulse articles are strategy-focused. I update the fair value estimates and rank every stock in my portfolio. I also consider...
Share
Cancer, Epidemiology
Ignyta Lights The Fire
Seeking AlphaStrong Bio
Summary Lead candidate entrectinib received FDA Breakthrough Therapy designation for treatment of advanced or metastatic solid tumors with select gene fusions. Gene fusion targeting continues to be a successful space in cancer treatment and is likely to be an area that bears...
Share
Manufacturing, Pfizer, Inc.
Bad Medicine! Pfizer, Cipla, DRL, other 63 drug firms fail quality test
The Economic Times of IndiaPrabha Raghavan
NEW DELHI: PfizerBSE -1.06 %, Dr Reddy’s Laboratories and CiplaBSE -0.96 % are among 66 drug makers that have some of their products failing quality tests carried out by the country’s drug regulator. Samples tested from these companies were found to be...
Share
GlaxoSmithKline plc, Health Finance
Sirukumab's Panel And U.S. Decision For Medicines Company
Seeking AlphaE.P. Vantage
Welcome to your weekly digest of approaching regulatory and clinical readouts. On August 2 a US FDA panel will review Johnson & Johnson's (NYSE:JNJ) anti-IL-6 MAb sirukumab, which if approved will enter a crowded rheumatoid arthritis market and face a battle against...
Share
Biotechnology, Cancer
Europe backs nuclear medicine for cancer that killed Steve Jobs
Reuters
LONDON (Reuters) - A nuclear medicine targeting the type of cancer that killed Steve Jobs won a green light from EU regulators on Friday, boosting prospects for its developer Advanced Accelerator Applications.
Share
Cancer, Health Care Industry
Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval
Reuters
(Reuters) - European regulators on Friday recommended approving Pfizer Inc and Merck KGaA's immuno-oncology drug Bavencio to treat a rare type of skin cancer called Merkel cell carcinoma.
Share
Campaign Finance, Finance
A Drug Maker Spends Big in Washington to Make Itself Heard
The New York TimesElizabeth Lucas, Jay Hancock, Sydney Lupkin
Two federal investigations — one examining opioid sales, another about a multiple sclerosis drug whose price had soared to $34,000 a vial — were only part of the troubles Mallinckrodt faced as the year began. The stock of the drug maker, whose...
Share
Manufacturing, Merck & Co., Inc.
Trump tweets promotion of pharmaceutical packaging initiative
Los Angeles TimesAssociated Press
President Trump tweeted video footage of his remarks Thursday at a White House event to promote a new packaging initiative announced by specialty glass maker Corning and pharmaceutical companies Merck & Co. and Pfizer Inc. The three companies have partnered to modernize...
Share